| pubmed-article:20308001 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20308001 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:20308001 | lifeskim:mentions | umls-concept:C0153381 | lld:lifeskim |
| pubmed-article:20308001 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:20308001 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:20308001 | pubmed:dateCreated | 2010-5-31 | lld:pubmed |
| pubmed-article:20308001 | pubmed:abstractText | Second primary tumours in patients treated for oral cancer occur at a rate of 3% to 7% per year. The majority of these tumours show up at least six months after the detection of the primary and are often located in the upper aerodigestive tract. Cessation of smoking habits may reduce the risk of the development of a second primary. There is no statistical significance between the oral subsite of the primary and the occurrence of a second primary. There are conflicting views in the literature on the survival rate of patients treated for a second primary in the head and neck region. | lld:pubmed |
| pubmed-article:20308001 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20308001 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20308001 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20308001 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20308001 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20308001 | pubmed:issn | 1368-8375 | lld:pubmed |
| pubmed-article:20308001 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:20308001 | pubmed:author | pubmed-author:de BreeRemcoR | lld:pubmed |
| pubmed-article:20308001 | pubmed:copyrightInfo | Copyright 2010 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:20308001 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20308001 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:20308001 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20308001 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20308001 | pubmed:pagination | 426-8 | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:meshHeading | pubmed-meshheading:20308001... | lld:pubmed |
| pubmed-article:20308001 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20308001 | pubmed:articleTitle | Second primary tumours in oral cancer. | lld:pubmed |
| pubmed-article:20308001 | pubmed:affiliation | VU University Medical Center, Academic Centre for Dentistry Amsterdam, Department of Oral and Maxillofacial Surgery/Pathology, The Netherlands. i.vanderwaal@vumc.nl | lld:pubmed |
| pubmed-article:20308001 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20308001 | pubmed:publicationType | Review | lld:pubmed |
